Link between spermine oxidase and apoptosis antagonizing transcription factor: A new pathway in neuroblastoma

Fratini,Emiliano; Cervelli,Manuela; Mariottini,Paolo; Kanamori,Yuta; Amendola,Roberto; Agostinelli,Enzo

doi:10.3892/ijo.2019.4878

Link between spermine oxidase and apoptosis antagonizing transcription factor: A new pathway in neuroblastoma

Authors:
- Emiliano Fratini
- Manuela Cervelli
- Paolo Mariottini
- Yuta Kanamori
- Roberto Amendola
- Enzo Agostinelli
View Affiliations

Affiliations: Department of Science, ‘Roma Tre’ University, I-00146 Rome, Italy, Department of Biochemical Sciences ‘A. Rossi Fanelli’, ‘La Sapienza’ University, I-00185 Rome, Italy, ENEA, UT Bio-Rad RAB, I-00123 Rome, Italy, International Polyamines Foundation - ONLUS, I-00159 Rome, Italy
Published online on: September 13, 2019 https://doi.org/10.3892/ijo.2019.4878
Pages: 1149-1156

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Neuroblastoma (NB) is a heterogeneous extra‑cranial childhood type of cancer, responsible for approximately 15% of all paediatric cancer‑related deaths. Although several critical genetic aberrations have been related to NB, only a few established molecular markers have been associated with prognosis [V‑myc avian myelocytomatosis viral oncogene (MYCN) locus amplification, deletions of part of chromosome 1p, 11q23 and gain of 17q]. Regrettably, direct evidence of NB‑related tumour suppressors or oncogenes has not been currently identified at these chromosomal regions. MYCN locus amplification is present in approximately 20‑30% of cases and is associated with a poor clinical outcome, representing the most important genetic prognostic marker. The functional guidelines for the prognosis of NB identify high‑risk patients (<40% survival probabilities), but fail to identify patients at low and intermediate stages of the disease, which remains an issue to be resolved in NB. It has been shown that in NB cell lines and in a total‑spermine oxidase (SMOX) transgenic mouse model, SMOX overexpression induces cellular stress via reactive oxygen species (ROS) imbalance. In this study, we demonstrated that the high expression level of the cytoprotective gene, apoptosis-antagonizing transcription factor (AATF), was driven by SMOX gene overexpression in both NB cells and Total‑SMOX mice. The anti‑apoptotic effect of AATF was supported by analysing the inhibition of the expression of the pro‑apoptotic genes, BAX, BAK and PUMA, which were decreased, in both the in vitro and in vivo SMOX overexpressing model systems investigated. On the whole, this study supports the hypothesis that the SMOX gene can be considered as a novel anti‑apoptotic marker in NB.

View Figures

View References

1	Brodeur GM and Maris JM: Neuroblastoma In: Principles and Practice of Pediatric Oncology. Pizzo PA and Poplack DG: JB Lippincott; Philadelphia: pp. 933–970. 2006
2	Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, Hesseling P, Shin HY, Stiller CA, Bouzbid S, et al IICC-3 contributors: International incidence of childhood cancer, 2001-10: A population-based registry study. Lancet Oncol. 18:719–731. 2017. View Article : Google Scholar : PubMed/NCBI
3	Brodeur GM: Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003. View Article : Google Scholar : PubMed/NCBI
4	Ngan ES: Heterogeneity of neuroblastoma. Oncoscience. 2:837–838. 2015.PubMed/NCBI
5	Maris JM, Hogarty MD, Bagatell R and Cohn SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
6	Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, et al Children's Oncology Group: Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med. 353:2243–2253. 2005. View Article : Google Scholar : PubMed/NCBI
7	Mlakar V, Jurkovic Mlakar S, Lopez G, Maris JM, Ansari M and Gumy-Pause F: 11q deletion in neuroblastoma: A review of biological and clinical implications. Mol Cancer. 16:1142017. View Article : Google Scholar : PubMed/NCBI
8	Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, et al: Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med. 340:1954–1961. 1999. View Article : Google Scholar : PubMed/NCBI
9	O'Leary M, Krailo M, Anderson JR and Reaman GH; Children's Oncology Group: Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group. Semin Oncol. 35:484–493. 2008. View Article : Google Scholar : PubMed/NCBI
10	Shimada H, Chatten J, Newton WA Jr, Sachs N, Hamoudi AB, Chiba T, Marsden HB and Misugi K: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuro-blastomas. J Natl Cancer Inst. 73:405–416. 1984. View Article : Google Scholar : PubMed/NCBI
11	Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R, Ernestus K, König R, Haas S, Eils R, et al: Customized oligo-nucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol. 24:5070–5078. 2006. View Article : Google Scholar : PubMed/NCBI
12	Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D, Seiser E, Jagannathan J, Shusterman S, Bansal M, et al: Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res. 66:6050–6062. 2006. View Article : Google Scholar : PubMed/NCBI
13	Schumacker PT: Reactive oxygen species in cancer cells: Live by the sword, die by the sword. Cancer Cell. 10:175–176. 2006. View Article : Google Scholar : PubMed/NCBI
14	Casero RA Jr and Marton LJ: Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov. 6:373–390. 2007. View Article : Google Scholar : PubMed/NCBI
15	Cervelli M, Angelucci E, Germani F, Amendola R and Mariottini P: Inflammation, carcinogenesis and neurodegeneration studies in transgenic animal models for polyamine research. Amino Acids. 46:521–530. 2014. View Article : Google Scholar
16	Cervelli M, Amendola R, Polticelli F and Mariottini P: Spermine oxidase: Ten years after. Amino Acids. 42:441–450. 2012. View Article : Google Scholar
17	Polticelli F, Salvi D, Mariottini P, Amendola R and Cervelli M: Molecular evolution of the polyamine oxidase gene family in Metazoa. BMC Evol Biol. 12:902012. View Article : Google Scholar : PubMed/NCBI
18	Amendola R, Bellini A, Cervelli M, Degan P, Marcocci L, Martini F and Mariottini P: Direct oxidative DNA damage, apoptosis and radio sensitivity by spermine oxidase activities in mouse neuro-blastoma cells. Biochim Biophys Acta. 1755:15–24. 2005.PubMed/NCBI
19	Bianchi M, Bellini A, Cervelli M, Degan P, Marcocci L, Martini F, Scatteia M, Mariottini P and Amendola R: Chronic sub-lethal oxidative stress by spermine oxidase overactivity induces continuous DNA repair and hypersensitivity to radiation exposure. Biochim Biophys Acta. 1773:774–783. 2007. View Article : Google Scholar : PubMed/NCBI
20	Ceci R, Duranti G, Leonetti A, Pietropaoli S, Spinozzi F, Marcocci L, Amendola R, Cecconi F, Sabatini S, Mariottini P, et al: Adaptive responses of heart and skeletal muscle to spermine oxidase overexpression: Evaluation of a new transgenic mouse model. Free Radic Biol Med. 103:216–225. 2017. View Article : Google Scholar : PubMed/NCBI
21	Cervelli M, Leonetti A, Duranti G, Sabatini S, Ceci R and Mariottini P: Skeletal muscle pathophysiology: The emerging role of spermine oxidase and spermidine. Med Sci (Basel). 6:62018.
22	Bruno T, De Nicola F, Iezzi S, Lecis D, D'Angelo C, Di Padova M, Corbi N, Dimiziani L, Zannini L, Jekimovs C, et al: Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint. Cancer Cell. 10:473–486. 2006. View Article : Google Scholar : PubMed/NCBI
23	Liu X, Cai S, Zhang C, Liu Z, Luo J, Xing B and Du X: Deacetylation of NAT10 by Sirt1 promotes the transition from rRNA biogenesis to autophagy upon energy stress. Nucleic Acids Res. 46:9601–9616. 2018. View Article : Google Scholar : PubMed/NCBI
24	Höpker K, Hagmann H, Khurshid S, Chen S, Hasskamp P, Seeger-Nukpezah T, Schilberg K, Heukamp L, Lamkemeyer T, Sos ML, et al: AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis. EMBO J. 31:3961–3975. 2012. View Article : Google Scholar : PubMed/NCBI
25	Sang Q, Liu X, Wang L, Qi L, Sun W, Wang W, Sun Y and Zhang H: Sun Y andZhang H: CircSNCA downregulation by pramipexole treatment mediates cell apoptosis and autophagy in Parkinson's disease by targeting miR-7. Aging (Albany NY). 10:62018.
26	Cervelli M, Bellini A, Bianchi M, Marcocci L, Nocera S, Polticelli F, Federico R, Amendola R and Mariottini P: Mouse spermine oxidase gene splice variants. Nuclear subcellular localization of a novel active isoform. Eur J Biochem. 271:760–770. 2004. View Article : Google Scholar : PubMed/NCBI
27	Cervelli M, Bellavia G, D'Amelio M, Cavallucci V, Moreno S, Berger J, Nardacci R, Marcoli M, Maura G, Piacentini M, et al: A new transgenic mouse model for studying the neurotoxicity of spermine oxidase dosage in the response to excitotoxic injury. PLoS One. 8:e648102013. View Article : Google Scholar : PubMed/NCBI
28	Pfaffl MW, Horgan GW and Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30:e362002. View Article : Google Scholar : PubMed/NCBI
29	Cadet J, Douki T, Gasparutto D and Ravanat JL: Oxidative damage to DNA: Formation, measurement and biochemical features. Mutat Res. 531:5–23. 2003. View Article : Google Scholar : PubMed/NCBI
30	Huang X, Okafuji M, Traganos F, Luther E, Holden E and Darzynkiewicz Z: Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin. Cytometry A. 58:99–110. 2004. View Article : Google Scholar : PubMed/NCBI
31	Amendola R, Cervelli M, Fratini E, Sallustio DE, Tempera G, Ueshima T, Mariottini P and Agostinelli E: Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments. Int J Oncol. 43:813–820. 2013. View Article : Google Scholar : PubMed/NCBI
32	Cervelli M, Fratini E, Amendola R, Bianchi M, Signori E, Ferraro E, Lisi A, Federico R, Marcocci L and Mariottini P: Increased spermine oxidase (SMO) activity as a novel differentiation marker of myogenic C2C12 cells. Int J Biochem Cell Biol 4. 1:934–944. 2009. View Article : Google Scholar
33	Cervelli M, Bellavia G, Fratini E, Amendola R, Polticelli F, Barba M, Federico R, Signore F, Gucciardo G, Grillo R, et al: Spermine oxidase (SMO) activity in breast tumor tissues and biochemical analysis of the anticancer spermine analogues BENSpm and CPENSpm. BMC Cancer. 10:5552010. View Article : Google Scholar : PubMed/NCBI
34	Pledgie A, Huang Y, Hacker A, Zhang Z, Woster PM, Davidson NE and Casero RA Jr: Spermine oxidase SMO(PAOh1), Not N¹-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H₂ O₂ in polyamine analogue-treated human breast cancer cell lines. J Biol Chem. 280:39843–39851. 2005. View Article : Google Scholar : PubMed/NCBI
35	Capone C, Cervelli M, Angelucci E, Colasanti M, Macone A, Mariottini P and Persichini T: A role for spermine oxidase as a mediator of reactive oxygen species production in HIV-Tat-induced neuronal toxicity. Free Radic Biol Med. 63:99–107. 2013. View Article : Google Scholar : PubMed/NCBI
36	Sun SY: N-acetylcysteine, reactive oxygen species and beyond. Cancer Biol Ther. 9:109–110. 2010. View Article : Google Scholar :
37	Fogel-Petrovic M, Vujcic S, Miller J and Porter CW: Differential post-transcriptional control of ornithine decarboxylase and spermidine-spermine N¹-acetyltransferase by polyamines. FEBS Lett. 391:89–94. 1996. View Article : Google Scholar : PubMed/NCBI
38	Mastrantonio R, Cervelli M, Pietropaoli S, Mariottini P, Colasanti M and Persichini T: HIV-Tat induces the Nrf2/ARE pathway through NMDA receptor-elicited spermine oxidase activation in human neuroblastoma cells. PLoS One. 11:e01498022016. View Article : Google Scholar : PubMed/NCBI
39	Pietropaoli S, Leonetti A, Cervetto C, Venturini A, Mastrantonio R, Baroli G, Persichini T, Colasanti M, Maura G, Marcoli M, et al: Glutamate Excitotoxicity Linked to Spermine Oxidase Overexpression. Mol Neurobiol. 55:7259–7270. 2018. View Article : Google Scholar : PubMed/NCBI
40	Caforio M, Sorino C, Iacovelli S, Fanciulli M, Locatelli F and Folgiero V: Recent advances in searching c-Myc transcriptional cofactors during tumorigenesis. J Exp Clin Cancer Res. 37:2392018. View Article : Google Scholar : PubMed/NCBI
41	Jing P, Zou J, Weng K and Peng P: The PI3K/AKT axis modulates AATF activity in Wilms' tumor cells. FEBS Open Bio. 8:1615–1623. 2018. View Article : Google Scholar : PubMed/NCBI